What Researchers Did
The researchers gave hyperbaric oxygen therapy to people with a sudden eye nerve problem caused by poor blood flow, and compared them with people who did not get it.
What They Found
In this pilot study, hyperbaric oxygen at 2.0 absolute atmospheres did not produce a significant improvement in vision or visual field in patients with acute nonarteritic anterior ischemic optic neuropathy, compared with untreated controls. Twenty-two eyes in 20 patients received two 90-minute sessions per day for ten days, and 27 untreated patients served as controls. Average visual acuity went up in both groups, and the rise was larger in the controls, but the difference was not statistically significant. Visual field sensitivity loss increased slightly, and the increase was smaller in the controls, again with no significant difference between groups. There was no significant difference in the share of patients whose acuity or field loss changed. Treating within nine days of symptom onset did not give better results than treating later or than no treatment.
What This Means for Canadian Patients
For people with this eye condition, this small study did not show a visual benefit from hyperbaric oxygen at 2.0 absolute atmospheres with 100% oxygen. The abstract does not say whether other protocols would give different results.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was a small pilot with 20 treated patients, and the abstract does not describe how patients were assigned to treatment or control, so the groups may not have been comparable.